Pharma

Russian Reports of Agreement to Produce Sputnik V in France Denied

Reading Time: < 1 minute

None of France’s pharmaceutical companies have signed a contract with Russia to produce its Sputnik V COVID-19 vaccine, a spokesman for France’s industry ministry said on Tuesday. The French reaction followed media reports by the head of Russia’s RDIF sovereign wealth fund stating an agreement had been sealed. Earlier, the head of RDIF said his organization had struck deals with production facilities in Italy, Spain, France and Germany to manufacture the Russian vaccine. “We have not identified a site which meets their requirements,” the French spokesperson added.

Source: Euractiv

CET Editor

Recent Posts

North Macedonia president loses big in first election round

No candidate received a majority of votes in the first round of the Presidential elections…

16 hours ago

Czech FM visits Budapest, as Hungary prepares for EU presidency

Hungary will focus on key issues for central Europe during its upcoming EU presidency, Hungarian…

17 hours ago

Westinghouse increasingly central to CEE’s shift from Russian nuclear industry

US nuclear firm Westinghouse Electric Company has signed memorandums of understanding (MOUs) with 17 Bulgarian…

4 days ago

AI will transform Adriatic economies – Microsoft

By 2030 Artificial Intelligence could be contributing as much as 11.5%, or USD 700bn (EUR…

7 days ago

CEE countries register EU’s highest, lowest inflation

Lithuania had the lowest annual inflation rate of 0.4% in the EU in March 2024,…

1 week ago

Lithuanians to vote on joint foreign citizenships next month

Lithuania will hold a constitutional referendum on whether its citizens can hold dual and multiple…

1 week ago